Copyright
©The Author(s) 2025.
World J Clin Cases. Nov 6, 2025; 13(31): 110624
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.110624
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.110624
Table 1 Melanoma-associated acute liver failure cases
| Ref. | Clinical presentation | History of cancer | Diagnosis method of liver disease | Treatment | Outcome |
| Current case | Diffuse abdominal pain, jaundice, hepatic encephalopathy; progressive ALF with multi-organ dysfunction | No prior cancer history; possible uveal melanoma based on visual symptoms; no autopsy | Liver biopsy; HMB-45-positive melanoma | Supportive ICU care (intubation, dialysis, vasopressors); considered for transplant until result of biopsy | Death on day 7 |
| O’Neill et al[3], 2024 | RUQ pain, myalgia, nausea, subjective fevers; fulminant ALF | Previously excised cutaneous melanoma (in situ) on upper back, 1 year prior | Histopathological diagnosis via core biopsy of left axillary lymph node (MART1, SOX10, HMB45-positive) | Dual immunotherapy (nivolumab + ipilimumab), IV terlipressin, ICU support | Death on day 17 post-presentation due to refractory encephalopathy and hepatorenal syndrome |
| Lee et al[4], 2022 | Nausea, vomiting, RUQ and LUQ pain, dyspepsia; fulminant ALF | No known history of melanoma; presumed first presentation, later verified suspicious skin lesions | Liver biopsy (S-100, HMB45, MART1-positive); stomach biopsy supportive | Supportive care; no specific antitumor therapy reported | Death shortly after liver biopsy; multiple organ failure before workup for primary site completed |
| Schlevogt et al[7], 2017 | Right flank pain; rapid deterioration to ALF with renal failure and encephalopathy | Malignant melanoma of right flank (3 years prior), recurrent cutaneous metastases; colorectal carcinoma resected 6 months prior | Liver biopsy (S100-positive; HMB45/MART1-negative) | BRAF-inhibitor (Vemurafenib) + MEK-inhibitor (Cobimetinib) | Death after one week 7 days; autopsy confirmed diffuse hepatic infiltration |
| Escobar-Valdivia et al[5], 2017 | RUQ pain, jaundice, weight loss, blindness in left eye; rapid ALF with encephalopathy | Undiagnosed uveal (choroidal) melanoma; visual impairment to blindness over 2 months, history revealed pigmented eye lesion 1 year prior | Post-mortem histopathology (liver and eye); coagulopathy precluded biopsy ante-mortem | Supportive care (FFP, vitamin K); no tumor-directed therapy | Death from multiorgan failure 4th in-hospital day; confirmed metastatic uveal melanoma on autopsy |
| Tanaka et al[11], 2015 | Left hand necrotic ulcer, erythema on trunk, no encephalopathy; later developed ALF | No known history of melanoma; diagnosed post-mortem as melanoma of unknown primary origin | Post-mortem histopathology and immunohistochemistry (HMB-45, S100-positive) | Palliative care; patient not eligible for systemic therapy due to poor performance status | Death on day 47; diffuse hepatic and splenic infiltration by melanoma confirmed on autopsy |
| Mashayekhi et al[12], 2014 | Jaundice, abdominal pain, oliguria; rapid ALF with multiorgan failure | Suspicious skin lesion (mole on back) noted 10 days before admission, not yet diagnosed or treated | Post-mortem histopathology; liver, heart, lung, kidney, bladder infiltrated with melanoma | Supportive care (antibiotics, fluids, inotropes); no tumor-directed therapy before death | Death on day 3; widespread multiorgan metastatic melanoma confirmed on autopsy |
| Bellolio et al[10], 2013 | Abdominal pain, jaundice, acholic stools, dark urine; rapid progression to fulminant hepatic failure | History of breast cancer treated 5 years prior; no known melanoma | Post-mortem histopathology; liver, spleen, and lymph nodes infiltrated with melanoma; HMB-45 and S-100-positive | Supportive care; rapid deterioration precluded biopsy or targeted therapy | Death shortly after admission; melanoma of unknown primary confirmed at autopsy |
| Tanaka et al[13], 2004 | Malaise, anorexia, abdominal distension, edema; ALF and encephalopathy, death within hours | No prior history; melanoma of unknown primary origin diagnosed post-mortem | Post-mortem histopathology; massive hepatic infiltration, melanoma cells in mesenteric lymph nodes | Supportive care only; rapid deterioration precluded therapeutic intervention | Death on hospital day 7; massive liver involvement, no primary site found on autopsy |
| Montero et al[8], 2002 | Jaundice, nausea, vomiting, general malaise; ALF with encephalopathy and renal failure | Supraciliary melanoma treated 18 months prior (Clark II, < 1 mm depth, negative margins) | Transjugular liver biopsy; diffuse sinusoidal infiltration by melanoma, HMB-45-positive | Standard liver failure therapy; no antitumor intervention | Death on day 10; progressive hepatic encephalopathy and renal dysfunction |
| Te et al[6], 1999 | Nausea, vomiting, RUQ pain, malaise; fulminant hepatic failure with encephalopathy and renal failure | Scalp lesion biopsied 2 months prior; initially non-diagnostic, later confirmed as melanoma | Percutaneous liver biopsy (HMB-45, S-100-positive); scalp mass re-biopsy-confirmed melanoma | Supportive therapy; chemotherapy deferred due to rapid deterioration | Death within 24 hours of encephalopathy onset; extensive sinusoidal infiltration confirmed histologically |
| Bouloux et al[9], 1986 | Hypochondrial pain, nausea, vomiting, jaundice, encephalopathy; rapid onset ALF and hepatorenal syndrome | Previously treated nodular melanoma (Clark IV, 5 mm depth) of right scapula; in situ melanoma of sacrum | Post-mortem histopathology; liver almost entirely replaced by melanoma, confirmed microscopically | Supportive care (vitamin K, neomycin, lactulose); no tumor-specific therapy given | Death on day 10; diffuse liver infiltration confirmed on autopsy |
- Citation: Domislovic V, Sesa V, Kosuta I, Bulimbasic S, Mrzljak A. Liver failure due to metastatic melanoma: A case report. World J Clin Cases 2025; 13(31): 110624
- URL: https://www.wjgnet.com/2307-8960/full/v13/i31/110624.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i31.110624
